Atorvastatin in Perioperative Vascular Surgery - Pilot Study
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG
coA reductase inhibitor class of drugs referred to as statins, will reduce cardiovascular
outcomes ( mortality - myocardial infarction - stroke ) when given in high doses in
comparative standard doses in the perioperative period of major vascular surgery.
Abdominal aortic aneurysm , Carotid endarterectomy , Revascularization of lower limbs